Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma

Journal of Gastroenterology

Volumn 35, Issue 5, 2000, Pages 353-360

  Ikeda, Kenji ^a,b   Saitoh, Satoshi ^a,b   Kobayashi, Masahiro ^a,b   Suzuki, Yoshiyuki ^a,b   Suzuki, Fumitaka ^a,b   Tsubota, Akihito ^a,b   Arase, Yasuji ^a,b   Chayama, Kazuaki ^a,b   Murashima, Naoya ^a,b   Kumada, Hiromitsu ^a,b  

^a TORANOMON HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

Arterio portal shunt; Hepatic artery obstruction; Hepatic atrophy; Hepatocellular carcinoma; Side effect; Styrene maleic acid neocarzinostatin

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; IODINATED POPPYSEED OIL; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BILOMA; BLOOD VESSEL SHUNT; CHOLANGITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RETENTION; FEMALE; HEPATIC ARTERY; HUMAN; LIVER ANGIOGRAPHY; LIVER ATROPHY; LIVER CELL CARCINOMA; LIVER CIRCULATION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; PRIORITY JOURNAL; VASCULAR DISEASE;

ADULT; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANTINEOPLASTIC AGENTS; ARTERIAL OCCLUSIVE DISEASES; ARTERIOVENOUS FISTULA; BIOPSY; CARCINOMA, HEPATOCELLULAR; CATHETERIZATION, PERIPHERAL; CHOLANGITIS; CONTRAST MEDIA; FEMALE; HEPATIC ARTERY; HUMANS; INCIDENCE; INJECTIONS, INTRA-ARTERIAL; IODIZED OIL; LIVER NEOPLASMS; MALE; MALEATES; MIDDLE AGED; POLYSTYRENES; PORTAL VEIN; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 18544394566     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050360     Document Type: Article

References (20)

1. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Cancer 1987;60:1400-11.
2. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathological features and results of surgical treatment. Ann Surg 1990;211:277-87.
3. Konno T, Maeda H, Iwai K, Tashiro S, Maki S, Morinaga T, et al. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Cancer Clin Oncol 1983; 19:1035-63.
4. Maeda H, Matsumoto T, Konno T, Iwai K, Ueda M. Tailor-making of protein drugs by polymer conjugation for tumor targeting: a brief review on Smancs. J Protein Chem 1984;3:181-93.
5. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs. Cancer Res 1986;46:6387-92.
6. Oda T, Maeda H. Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer. Cancer Res 1987; 47:3206-11.
7. Ohtsuka N, Konno T, Miyauchi Y, Maeda H. Anticancer effects of arterial administration of the anticancer agent SMANCS with Lipiodol on metastatic lymph nodes. Cancer 1987;59:1560-5.
8. Konno T. Targeting chemotherapy for hepatoma: arterial administration of anticancer drugs dissolved in Lipiodol. Eur J Cancer 1992;28:403-9.
9. Jinno K, Moriwaki S, Tanada M, Wada T, Mandai K, Okada Y, Clinicopathological study on combination therapy consisting of arterial infusion of Lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 1992;31(Suppl I):S7-S12.
10. Ikeda K, Saitoh S, Suzuki Y, Tsubota A, Koida I, Kobayashi M, et al. Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer: a pilot study. J Gastroenterol 1997;32:513-20.
11. Ikeda K, Saitoh S, Suzuki Y, Tsubota A, Kobayashi M, Koida I, et al. Effect of arterial administration of a high molecular weight antitumor agent styrene maleic acid neocarzinostatin for embolization-resistant liver cancer. Int J Clin Oncol 1999;4:148-55.
12. Fujita M, Inoue E, Kuroda C, Kasugai H, Sasaki Y, Nakano H, Imaoka S. Our initial experience with SMANCS in TAE for liver cancer (English abstract). Jpn J Cancer Chemother 1998;25 (Suppl I):105-8.
13. Sakaguchi T, Yoshimatsu S, Sagara K, Yamashita Y, Takahashi M. Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma: adverse reactions and complications (English abstract). Jpn J Cancer Chemother 1998;25(Suppl I):64-9.
14. Ihaya T, Ametani M, Matsusue E. Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma (English abstract). Jpn J Cancer Chemother 1998;25(Suppl I):109-15.
15. Suzuki M, Fukuhara K, Unno M, Endoh K, Takeuchi H, Kodama H, et al. Advantages and disadvantages of SMANCS-Lipiodol intrahepatic infusion chemotherapy for unresectable hepatocellular carcinoma (English abstract). Jpn J Cancer Chemother 1998; 25(Suppl I):39-45.
16. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography. Acta Radiol 1952;39:368-76.
17. Maki S, Konno T, Maeda H. Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer 1985;56:751-7.
18. Ikeda K, Saitoh S, Koida I, Tsubota A, Arase Y, Chayama K, Kumada H. A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Am J Clin Oncol 1995;18:204-10.
19. Okada S, Okazaki N, Nose H, Yoshimori M, Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 1992;16:112-7.
20. Ikeda K, Saitoh S, Suzuki Y, Koida I, Tsubota A, Kobayashi M, et al. A prospective randomized administration of 5′-deoxy-5-fluorouridine as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Am J Clin Oncol 1997;20:202-8.